Stay updated on XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Sign up to get notified when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.

Latest updates to the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page
- CheckyesterdayChange DetectedDifference0.3%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedDifference0.3%
- Check23 days agoChange DetectedThe page has been updated to include new information about the drug Plerixafor and its use in stem cell transplants, while removing detailed comparisons of different drugs used in the study.SummaryDifference17%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page has been updated to include information on Multiple Myeloma and has been revised to version 2.14.3, while references to Lymphosarcoma and the previous version 2.14.2 have been removed.SummaryDifference0.2%
Stay in the know with updates to XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.